Off-label use of rFVIIa and its clinical effectiveness: results from a Scottish national audit

被引：0
|
作者：
Gallipoli, P.
Robertson, M.
Tait, R. C.
机构：
[1] Glasgow Royal Infirm, Dept Haematol, Glasgow G4 0SF, Lanark, Scotland
[2] Royal Alexandra Hosp, Dept Haematol, Paisley, Renfrew, Scotland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2007年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
248
引用
收藏
页码：85 / 85
页数：1
相关论文
共 50 条
  • [1] Off-label use of rFVIIa and its clinical effectiveness: Results from a Scottish national audit
    Gallipoli, P.
    Robertson, M.
    Tait, R. C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 31 - 32
  • [2] Thromboembolic events a risk in off-label use of rFVIIa
    Reactions Weekly, 2010, 1327 (1) : 2 - 2
  • [3] Off-label use of rFVIIa in critical bleeding: the Padua experience
    Sartori, M.
    Imbergamo, S.
    Zanon, E.
    Bonaccorso, G.
    Feltracco, P.
    Cella, G.
    HAEMOPHILIA, 2008, 14 : 14 - 14
  • [4] Off-Label Use of rFVIIa in Children With Excessive Bleeding: A Consecutive Study of 153 Off-Label Uses in 139 Children
    Young, Guy
    Wicklund, Brian
    Neff, Philip
    Johnson, Chelsea
    Nugent, Diane J.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (02) : 179 - 183
  • [5] A clinical audit of high-cost and off-label drug use in dermatology
    Ong, Natalie
    McMeniman, Erin
    Pillans, Peter
    Soyer, H. Peter
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 (01) : 30 - 34
  • [6] CLINICAL EFFECTIVENESS OF OFF-LABEL IVACAFTOR USE IN PATIENTS WITH CYSTIC FIBROSIS
    Hoag, J. B.
    Stephen, M. J.
    Dorgan, D.
    Bonk, M.
    Alaag, P.
    Hadjiliadis, D.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 294 - 294
  • [7] Off-label use of recombinant activated factor VII (rFVIIa) in children.
    Punzalan, RC
    Ghanayem, NS
    Gill, JC
    Jaquiss, RDB
    Montgomery, RR
    Gottschall, JL
    BLOOD, 2003, 102 (11) : 137B - 137B
  • [8] Off-label use of maraviroc in clinical practice
    Blanco, Jose-Ramon
    Ochoa-Callejero, Laura
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (01) : 5 - 8
  • [9] Off-label use of recombinant factor VII (rFVIIa) in teaching hospitals in Paris in 2010
    Bardon, J.
    Fink, J.
    de Montblanc, J.
    Bergmann, J-F
    Sarrut, B.
    Benhamou, D.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2013, 32 (10): : 659 - 664
  • [10] National Trends in Pediatric Use of Anticonvulsants: On and Off-Label
    Tran, Allen R.
    Julie, Zito M.
    Daniel, Safer J.
    Sarah, Hundley
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S321 - S322
12345